O'Connor R M, Kim K, Khan F, Ward H D
Division of Geographic Medicine and Infectious Diseases, Tufts-New England Medical Center, 50 Washington Street, Boston, MA 02111, USA.
Infect Immun. 2003 Oct;71(10):6027-34. doi: 10.1128/IAI.71.10.6027-6034.2003.
Cryptosporidium parvum is a waterborne enteric coccidian that causes diarrheal disease in a wide range of hosts. Development of successful therapies is hampered by the inability to culture the parasite and the lack of a transfection system for genetic manipulation. The glycoprotein products of the Cpgp40/15 gene, gp40 and gp15, are involved in C. parvum sporozoite attachment to and invasion of host cells and, as such, may be good targets for anticryptosporidial therapies. However, the function of these antigens appears to be dependent on the presence of multiple O-linked alpha-N-acetylgalactosamine (alpha-GalNAc) determinants. A eukaryotic expression system that would produce proteins bearing glycosylation patterns similar to those found on the native C. parvum glycoproteins would greatly facilitate the molecular and functional characterization of these antigens. As a unique approach to this problem, the Cpgp40/15 gene was transiently expressed in Toxoplasma gondii, and the expressed recombinant glycoproteins were characterized. Antisera to gp40 and gp15 reacted with the surface membranes of tachyzoites expressing the Cpgp40/15 construct, and this reactivity colocalized with that of antiserum to the T. gondii surface protein SAG1. Surface membrane localization was dependent on the presence of the glycophosphatidylinositol anchor attachment site present in the gp15 coding sequence. The presence of terminal O-linked alpha-GalNAc determinants on the T. gondii recombinant gp40 was confirmed by reactivity with Helix pomatia lectin and the monoclonal antibody 4E9, which recognizes alpha-GalNAc residues, and digestion with alpha-N-acetylgalactosaminidase. In addition to appropriate localization and glycosylation, T. gondii apparently processes the gp40/15 precursor into the gp40 and gp15 component glycopolypeptides, albeit inefficiently. These results suggest that a surrogate system using T. gondii for the study of Cryptosporidium biology may be useful.
微小隐孢子虫是一种通过水传播的肠道球虫,可在多种宿主中引起腹泻病。由于无法培养该寄生虫以及缺乏用于基因操作的转染系统,成功疗法的开发受到阻碍。Cpgp40/15基因的糖蛋白产物gp40和gp15参与微小隐孢子虫子孢子对宿主细胞的附着和入侵,因此可能是抗隐孢子虫疗法的良好靶点。然而,这些抗原的功能似乎依赖于多个O-连接的α-N-乙酰半乳糖胺(α-GalNAc)决定簇的存在。一个能产生具有与天然微小隐孢子虫糖蛋白相似糖基化模式的蛋白质的真核表达系统,将极大地促进这些抗原的分子和功能特性研究。作为解决这个问题的独特方法,Cpgp40/15基因在刚地弓形虫中瞬时表达,并对表达的重组糖蛋白进行了特性分析。针对gp40和gp15的抗血清与表达Cpgp40/15构建体的速殖子表面膜发生反应,这种反应性与针对刚地弓形虫表面蛋白SAG1的抗血清的反应性共定位。表面膜定位依赖于gp15编码序列中存在的糖基磷脂酰肌醇锚定附着位点。通过与苹果蜗牛凝集素和识别α-GalNAc残基的单克隆抗体4E9反应以及用α-N-乙酰半乳糖胺酶消化,证实了刚地弓形虫重组gp40上存在末端O-连接的α-GalNAc决定簇。除了适当的定位和糖基化外,刚地弓形虫显然将gp40/15前体加工成gp40和gp15组成的糖多肽,尽管效率不高。这些结果表明,使用刚地弓形虫作为研究隐孢子虫生物学的替代系统可能是有用的。